<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8900963</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1466</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Neurobiol.</journal-id>
<journal-title-group>
<journal-title>Molecular neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-7648</issn>
<issn pub-type="epub">1559-1182</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30666562</article-id>
<article-id pub-id-type="pmc">6616013</article-id>
<article-id pub-id-type="doi">10.1007/s12035-019-1477-6</article-id>
<article-id pub-id-type="manuscript">NIHMS1519268</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expression of a fragment of Ankyrin 2 disrupts the structure of the Axon Initial Segment and causes axonal degeneration in <italic>Drosophila</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Spurrier</surname>
<given-names>Joshua</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shukla</surname>
<given-names>Arvind Kumar</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buckley</surname>
<given-names>Tyler</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith-Trunova</surname>
<given-names>Svetlana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuzina</surname>
<given-names>Irina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Qun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giniger</surname>
<given-names>Edward</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8340-6158</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bldg 35, Rm 1C-1002, 35 Convent Dr, Bethesda, MD, 20892, USA</aff>
<aff id="A2"><label>2</label>Current address: Cellular Neuroscience, Neurodegeneration and Repair Program, Department of Neurology, Yale University School of Medicine, New Haven, CT, USA</aff>
<aff id="A3"><label>3</label>Current address: The Scripps Research Institute, San Diego, CA, USA</aff>
<aff id="A4"><label>4</label>Current address: US Army Research Institute of Infectious Diseases, Frederick, MD, USA</aff>
<author-notes>
<fn id="FN1">
<label>#</label>
<p id="P1">These authors contributed equally to this work</p>
</fn>
<corresp id="CR1"><label>*</label><bold>Corresponding author</bold>: Edward Giniger, <email>ginigere@ninds.nih.gov</email>, Tel: 1-301-451-3890</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>56</volume>
<issue>8</issue>
<fpage>5689</fpage>
<lpage>5700</lpage>
<!--elocation-id from pubmed: 10.1007/s12035-019-1477-6-->
<abstract id="ABS1">
<p id="P2">Neurodegenerative stimuli are often associated with perturbation of the axon initial segment (AIS), but it remains unclear whether AIS disruption is causative for neurodegeneration or is a downstream step in disease progression. Here we demonstrate that either of two separate, genetically parallel pathways that disrupt the AIS induce axonal degeneration and loss of neurons in the central brain of <italic>Drosophila</italic>. Expression of a portion of the C-terminal tail of the Ank2-L isoform of Ankyrin severely shortens the AIS in <italic>Drosophila</italic> mushroom body (MB) neurons, and this shortening occurs through a mechanism that is genetically separate from the previously described <italic>Cdk5Î±</italic>-dependent pathway of AIS regulation. Further, either manipulation triggers morphological degeneration of MB axons and is accompanied by neuron loss. Taken together, our results are consistent with the hypothesis that disruption of the AIS is causally related to degeneration of fly central brain neurons, and we suggest that similar mechanisms may contribute to neurodegeneration in mammals.</p>
</abstract>
<kwd-group>
<kwd>Axon Initial Segment</kwd>
<kwd>Axonal degeneration</kwd>
<kwd>Neurodegeneration</kwd>
<kwd>Ankyrin 2</kwd>
<kwd>Cdk5</kwd>
<kwd>Drosophila</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>